Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot evaluation of cinacalcet-induced suppression of parathyroid hormone secretion
2009-017463-41Phase 4Active
- Sponsor
- Rouen University Hospital
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cinacalcet and calcium gluconate in primary hyperparathyroidism (PHPT) (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Plasma parathyroid hormone concentration at 360 minutes. Started Dec 2009; status: active.
02
Drugs
cinacalcetcalcium gluconate
03
Conditions
primary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on 2009-017463-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017463-41.